I will say that the one thing that has me a little concerned is the inability of either BMSN/Regen/Koos to answer ANY emails from investors. I've never heard anyone get an answer to any attempt at outreach.

To answer an earlier question, I think after IND approval, you'll see it in the .02-.06 range and hover on the higher end ~.05 until results from the trials are released. If positive, then BMSN could shoot up to around .10. I think this is by EOY. All my personal speculation of course. For a good comparable example, I think you can look at ACTC https://www.google.com/finance?cid=668509. Similar A/S and O/S (2.19 billion) and it's hovering around 6-7 cents with a market cap of 164 million. Compare that to us (one IND application in, another being prepared) with a market cap of roughly 4-5 million. This stock is definitely undervalued in both the short term and long term. I personally plan on flipping about 1/3 of my shares out at .015 and riding free shares the rest of the way.